BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Lone Star Bio

  Lexicon Pharmaceuticals, Inc. to Provide Second Quarter 2012 Financial Results

  July 24, 2012

   · 

  2 min read
• Business

  Insmed Incorporated to Host 2012 Second Quarter Earnings Conference Call

  July 24, 2012

   · 

  3 min read
• Biotech Bay

  Thoratec Corporation Schedules Second Quarter Conference Call, Webcast

  July 24, 2012

   · 

  1 min read
• Drug Development

  NeurogesX, Inc. Partner Astellas Pharma Inc. Enrolls First Patient in EU Clinical Trial for QUTENZA(R) (8% Capsaicin Patch)

  July 24, 2012

   · 

  1 min read
• Drug Development

  XenoPort, Inc. Announces Initiation of a Phase 1 Clinical Trial of XP23829, a Novel Fumarate Analog for the Potential Treatment of Relapsing-Remitting Multiple Sclerosis and Psoriasis

  July 24, 2012

   · 

  1 min read
• Biotech Bay

  New Comprehensive High Throughput Screening Study Finds HTS Laboratories Continue to Use New Approaches and Technologies to Increase Drug Discovery Success

  July 24, 2012

   · 

  1 min read
• Business

  Biogen Idec, Inc. (Massachusetts) Increases Revenue 18% to $1.4 Billion in the Second Quarter

  July 24, 2012

   · 

  1 min read
• BioMidwest

  Transgenomic, Inc. Announces Medicare Coverage for Clopidogrel (Plavix®) Response Test

  July 24, 2012

   · 

  1 min read
• Drug Development

  ANTISENSE PHARMA GmbH Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma

  July 24, 2012

   · 

  6 min read
• Genetown

  iCAD, Inc. Launches Next-Generation Mammography CAD Platform

  July 24, 2012

   · 

  1 min read